This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (funded, already peer-reviewed, non-eHealth) (172) Cardiac Disease Management (94) Pharmacology and Pharmaceutics (66) Drug Repurposing and Off-Label Use (25) Chronic Conditions (270)

Published on in Vol 10, No 5 (2021): May

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/22533, first published .
Treatment of Barth Syndrome by Cardiolipin Manipulation (CARDIOMAN) With Bezafibrate: Protocol for a Randomized Placebo-Controlled Pilot Trial Conducted in the Nationally Commissioned Barth Syndrome Service

Treatment of Barth Syndrome by Cardiolipin Manipulation (CARDIOMAN) With Bezafibrate: Protocol for a Randomized Placebo-Controlled Pilot Trial Conducted in the Nationally Commissioned Barth Syndrome Service

Treatment of Barth Syndrome by Cardiolipin Manipulation (CARDIOMAN) With Bezafibrate: Protocol for a Randomized Placebo-Controlled Pilot Trial Conducted in the Nationally Commissioned Barth Syndrome Service

Authors of this article:

Lucy Dabner1 Author Orcid Image ;   Guido E Pieles2, 3 Author Orcid Image ;   Colin G Steward4 Author Orcid Image ;   Julian P Hamilton-Shield5 Author Orcid Image ;   Andrew R Ness5, 6 Author Orcid Image ;   Chris A Rogers1 Author Orcid Image ;   Chiara Bucciarelli-Ducci3, 7 Author Orcid Image ;   Rosemary Greenwood8 Author Orcid Image ;   Lucy Ellis1 Author Orcid Image ;   Karen Sheehan9 Author Orcid Image ;   Barnaby C Reeves1 Author Orcid Image
Article Authors Cited by (13) Tweetations (4) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.